Leila Husseini

Goettingen, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Journal: Neurology

Published: July 02, 2026

Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis.

Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis.

Journal: Acta neuropathologica communications

Published: July 29, 2025

Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Journal: BMJ neurology open

Published: May 25, 2025

B cell CD19 is transferred between immune cells in mice and humans.

B cell CD19 is transferred between immune cells in mice and humans.

Journal: Nature communications

Published: April 22, 2025

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 19, 2024

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 11, 2024

Toward identifying key mechanisms of progression in multiple sclerosis.

Toward identifying key mechanisms of progression in multiple sclerosis.

Journal: Trends in neurosciences

Published: July 25, 2023

B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.

B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 10, 2020

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.

Journal: Journal of neuroinflammation

Published: May 29, 2019

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.

Journal: Therapeutic advances in neurological disorders

Published: September 14, 2012

An emboligenic pulmonary abscess leading to ischemic stroke and secondary brain abscess.

An emboligenic pulmonary abscess leading to ischemic stroke and secondary brain abscess.

Journal: BMC neurology

Published: June 12, 2012

Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.

Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: March 06, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026